Adam O'Dell left medical school over 20 years ago. He's been showing readers winning trades ever since — including a recent play on Adaptive Biotechnologies that has gone as high as 280% in just 24 months.
Today, he's revealing his top biotech stock to own right now.
In his words: "This tiny Boston-based AI biotech holds 179 patents on a medical breakthrough I expect to blossom into a $1 trillion industry. Its shares won't trade under $5 for long."
Matt Clark, CMSA® Chief Research Analyst, What My System Says Today
(c) 2026 Money & Markets. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Money & Markets. 1001 Cathedral Street, Baltimore, MD 21201. (TEL: 866-584-4096) Legal Notice
The mailbox associated with this email address is not monitored, so please do not reply.
Your feedback is very important to us so if you would like to contact us with a question or comment, please click here.
Post a Comment
Post a Comment